Medical Device Registration in Russia. Challenges and Issues

Webinar: Medical Device Registration in Russia. Challenges and Issues

The purpose of this webinar is to show the differences and specifics of regulations and law processes that can cause challenges in medical device registration in Russia.

 

You will learn about:

1. The specificity of national classification of medical devices

  • What is a Medical Device and what is not a Medical Device?
  • Why some medical products are medical devices in the EU but not considered as medical devices in Russia?

2. Key issues with the registration of complex and multi-component medical devices

  • Complex IVD Systems
  • Multi-component MD (Construction Kit)
  • MD with measuring function
  • Dermal Fillers with Lidocaine
  • Drug-Device combinations

3. National approach to Medical Software (SaMD)

 

Expanding into the Russian market?

Make use of our experts to guide you from the start to a full market access. Explore your options in a chat with one of our experts.

Who should attend? Professionals from Medical Device companies working within:

  • Regulatory
  • R&D
  • QA/QC
  • Compliance
  • Product Development
  • Manufacturing

Duration: 45 min.

Speaker: Regulatory Affairs Project Manager, Mikhail Vinogradov, LLM, who will discuss the key challenges and issues arising from the complex system of Medical Device registration in Russia.

Mikhail Vinogradov, LLM

Mikhail Vinogradov, LLM

Regulatory Affairs Project Manager

Other content that might interest you:

Marketing Authorization Process in Russia

Marketing Authorization Process in Russia

Cultural and language problems are a frequent stumbling block for multinational corporations seeking to register drugs in Russia. Additionally, the Marketing Authorization process in Russia is highly complex, and the paperwork frequently changes as the regulatory...

read more
Drug Registration in Russia

Drug Registration in Russia

 Overview of drug registration in Russia The Russian pharmaceutical industry is expected to exceed two trillion Russian rubles in 2020, representing a roughly 10% growth over the previous year. Pharmaceutical revenues are expected to reach 2.35 trillion Russian rubles...

read more

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information